Summary & Overview
HCPCS L6882: Microprocessor Control Feature for Upper Limb Prosthetic Terminal Device
HCPCS Level II code L6882 denotes a microprocessor control feature added to an upper limb prosthetic terminal device. The code identifies an electronic component intended to enhance prosthetic terminal function through microprocessor-driven control, reflecting advances in upper limb prosthetic technology. Nationally, accurate coding of such components matters for proper coverage determinations, device tracking, and claims consistency as microprocessor-controlled prostheses become more common in rehabilitative care.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what L6882 represents clinically and operationally, typical sites of service where the component is provided, and the payers commonly involved in coverage decisions. The publication covers coding context, expected billing practices, common modifiers used with HCPCS Level II prosthetic items, and where to find policy and coverage guidance. It also highlights considerations for documentation and claim submission related to prosthetic component additions. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code L6882 describes a microprocessor control feature, addition to upper limb prosthetic terminal device. This billing descriptor indicates an electronic enhancement integrated into an upper limb prosthesis terminal device to provide microprocessor-driven control functions.
-
Service type: Prosthetic device component — microprocessor control feature for upper limb terminal device
-
Typical site of service: Prosthetics and orthotics clinic, durable medical equipment supplier, or outpatient rehabilitation setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 42-year-old patient with a transradial amputation of the dominant upper limb presents for prosthetic fitting. The patient is receiving an active terminal device (myoelectric hand) and the prosthetist documents functional limitations with grip pattern selection and the need for improved adaptive control in variable tasks. The team elects to add a microprocessor control feature to the existing upper limb prosthetic terminal device to improve digit sequencing, adaptive grip modulation, and user interface responsiveness. The clinical workflow includes: a pre-prosthetic evaluation by a certified prosthetist; baseline functional and activity-of-daily-living assessments; ordering and approval of the L6882 add-on microprocessor control feature; fabrication and integration into the terminal device by the prosthetic technician; device programming and calibration in the clinic; in-person training and functional testing with occupational therapy; and follow-up adjustments and documentation of functional improvement and justification for the additional component.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Anesthesia modifier - Not typically used for prosthetic component billing | Not applicable for L6882 except in rare facility anesthetic billing situations |